SUN03 Pediatric Dermatology in Diverse Populations and Healthcare Settings
DESCRIPTION
Literature suggests race, ethnicity, socioeconomic status, and gender diversity affect care in pediatric dermatology. This session will be a case-based discussion of the diagnosis, treatment, and management of pediatric skin disease (including vitiligo, acne, hidradenitis suppurativa, and psoriasis) in underserved and/or minority populations, including gender diverse populations, to better understand issues of healthcare equity and improve diagnosis and treatment in pediatric dermatology. The intended audience is dermatologists who encounter pediatric patients, with intent to provide increased exposure to presentation in diverse patients as well as to highlight disparities in access and care, ultimately to improve healthcare outcomes for vulnerable populations.
LEARNING OBJECTIVES
Recognize and diagnose pediatric skin disease in marginalized populations, including racial, socioeconomic and gender minorities.
Identify considerations for treatment of children and adolescents in resource-limited and community health settings.
Discuss the impact of equity on the management of pediatric skin disease.
SCHEDULE
2:30 PM
Introduction
Anna Cristina Garza-Mayers, MD, PhD, FAAD
2:40 PM
Acne Treatment in Transgender and Gender Diverse Populations
Markus Boos, PhD, MD, FAAD
3:00 PM
Adolescents and Tools for Shared Decision Making in Hidradenitis Suppurativa and Other Diseases
George K Hightower, MD, FAAD
3:20 PM
Q&A
SPEAKERS
Markus Boos, PhD, MD, FAAD
Anna Cristina Garza-Mayers, MD, PhD, FAAD
George K Hightower, MD, FAAD
SPEAKER DISCLOSURES
Markus Boos, PhD, MD, FAAD
Regeneron Pharmaceuticals, Inc. – Investigator(No Compensation Received);
Anna Cristina Garza-Mayers, MD, PhD, FAAD
Sanofi/Regeneron – Advisory Board(Honoraria);
George K Hightower, MD, FAAD
No financial relationships exist with ineligible companies.